18 marzo 2015
A new study is assessing patients with metastasized bowel cancer to determine whether it is possible to characterize tumor and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/v2X_qqJTb-Q/150318074234.htm
